Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
Lisata Therapeutics, Inc. is a clinical-stage pharmaceutical company focused on developing innovative therapies for solid tumors and major diseases. Its lead investigational drug, certepetide, enhances delivery and efficacy of anti-cancer treatments by activating a tumor-specific transport pathway. The company targets cancers like pancreatic ductal adenocarcinoma, leveraging its proprietary CendR platform to improve treatment outcomes through combination therapies and collaborations.
This description was generated via AI from an annual report. Updated about 1 year ago.